Literature DB >> 18567838

Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Bonnie K Arendt1, Marina Ramirez-Alvarado, Laura A Sikkink, Jonathan J Keats, Gregory J Ahmann, Angela Dispenzieri, Rafael Fonseca, Rhett P Ketterling, Ryan A Knudson, Erin M Mulvihill, Renee C Tschumper, Xiaosheng Wu, Steven R Zeldenrust, Diane F Jelinek.   

Abstract

Primary systemic amyloidosis (AL) is a rare monoclonal plasma cell (PC) disorder characterized by the deposition of misfolded immunoglobulin (Ig) light chains (LC) in vital organs throughout the body. To our knowledge, no cell lines have ever been established from AL patients. Here we describe the establishment of the ALMC-1 and ALMC-2 cell lines from an AL patient. Both cell lines exhibit a PC phenotype and display cytokine-dependent growth. Using a comprehensive genetic approach, we established the genetic relationship between the cell lines and the primary patient cells, and we were also able to identify new genetic changes accompanying tumor progression that may explain the natural history of this patient's disease. Importantly, we demonstrate that free lambda LC secreted by both cell lines contained a beta structure and formed amyloid fibrils. Despite absolute Ig LC variable gene sequence identity, the proteins show differences in amyloid formation kinetics that are abolished by the presence of Na(2)SO(4). The formation of amyloid fibrils from these naturally secreting human LC cell lines is unprecedented. Moreover, these cell lines will provide an invaluable tool to better understand AL, from the combined perspectives of amyloidogenic protein structure and amyloid formation, genetics, and cell biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567838      PMCID: PMC2518895          DOI: 10.1182/blood-2008-03-143040

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  66 in total

Review 1.  Therapy for immunoglobulin light chain amyloidosis: the new and the old.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

2.  Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.

Authors:  Jonathan S Wall; Vibha Gupta; Matthew Wilkerson; Maria Schell; Remy Loris; Paul Adams; Alan Solomon; Fred Stevens; Chris Dealwis
Journal:  J Mol Recognit       Date:  2004 Jul-Aug       Impact factor: 2.137

3.  Intracellular localization of human amyloid by fluorescence and electron microscopy.

Authors:  D Zucker-Franklin; E C Franklin
Journal:  Am J Pathol       Date:  1970-04       Impact factor: 4.307

4.  DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A.

Authors:  Steven Bergink; Florian A Salomons; Deborah Hoogstraten; Tom A M Groothuis; Harm de Waard; Junxin Wu; Li Yuan; Elisabetta Citterio; Adriaan B Houtsmuller; Jacques Neefjes; Jan H J Hoeijmakers; Wim Vermeulen; Nico P Dantuma
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

5.  An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).

Authors:  Ken-ichiro Otsuyama; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

6.  Characterization of the P5 subfamily of P-type transport ATPases in mice.

Authors:  Patrick J Schultheis; Tamara T Hagen; Kate K O'Toole; Akiko Tachibana; Charles R Burke; Diana L McGill; Gbolahan W Okunade; Gary E Shull
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

7.  AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.

Authors:  John Keeling; Jiamin Teng; Guillermo A Herrera
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

8.  Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns.

Authors:  Jiamin Teng; William J Russell; Xin Gu; James Cardelli; M Lamar Jones; Guillermo A Herrera
Journal:  Lab Invest       Date:  2004-04       Impact factor: 5.662

9.  Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.

Authors:  Cristina Largo; Sara Alvarez; Borja Saez; David Blesa; Jose I Martin-Subero; Ines González-García; Jose A Brieva; Joaquin Dopazo; Reiner Siebert; María J Calasanz; Juan C Cigudosa
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

10.  Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

Authors:  Daniel A Brenner; Mohit Jain; David R Pimentel; Bo Wang; Lawreen H Connors; Martha Skinner; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

View more
  42 in total

1.  Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels.

Authors:  Alexandra J Greenberg; Denise K Walters; Shaji K Kumar; S Vincent Rajkumar; Diane F Jelinek
Journal:  Eur J Haematol       Date:  2013-09-17       Impact factor: 2.997

2.  In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.

Authors:  Elena S Klimtchuk; Tatiana B Prokaeva; Brian H Spencer; Olga Gursky; Lawreen H Connors
Journal:  Amyloid       Date:  2017-06-20       Impact factor: 7.141

3.  Quantitative Interactome Proteomics Reveals a Molecular Basis for ATF6-Dependent Regulation of a Destabilized Amyloidogenic Protein.

Authors:  Lars Plate; Bibiana Rius; Bianca Nguyen; Joseph C Genereux; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Chem Biol       Date:  2019-05-16       Impact factor: 8.116

4.  Evolutionary dynamics of two related malignant plasma cell lines.

Authors:  David Dingli; Bonnie K Arendt; Zeljko Bajzer; Diane F Jelinek
Journal:  Cell Cycle       Date:  2010-09-15       Impact factor: 4.534

5.  Role of domain interactions in the aggregation of full-length immunoglobulin light chains.

Authors:  Enrico Rennella; Gareth J Morgan; Jeffery W Kelly; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

6.  CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.

Authors:  Denise K Walters; Bonnie K Arendt; Diane F Jelinek
Journal:  Cell Cycle       Date:  2013-09-03       Impact factor: 4.534

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

Authors:  Gareth J Morgan; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2016-08-26       Impact factor: 5.469

Review 9.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.

Authors:  Tanya L Poshusta; Laura A Sikkink; Nelson Leung; Raynell J Clark; Angela Dispenzieri; Marina Ramirez-Alvarado
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.